Complementary therapies, herbs, and other OTC agents.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2009 AND VI 23 AND IP 7
Results: 37
1
2
Continuing medical education: CME post-test.
- Published in:
- 2009
- Publication type:
- Journal Article
3
Vaccine improves response rate and extends progression-free survival in metastatic melanoma.
- Published in:
- 2009
- Publication type:
- Journal Article
4
Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma.
- Published in:
- 2009
- Publication type:
- Journal Article
5
'Natural' hormone replacement for breast cancer risk: evidence for safety and efficacy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
6
PARP inhibitors show promise for hard-to-treat breast cancers.
- Published in:
- 2009
- Publication type:
- Journal Article
7
The role of LHRH antagonists in the treatment of prostate cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
8
Is there a role for LHRH antagonists in prostate cancer?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
9
Maintenance therapy with pemetrexed improves overall survival in advanced NSCLC.
- Published in:
- 2009
- Publication type:
- Journal Article
10
Important considerations in LHRH antagonist therapy for prostate cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
11
Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma: part 2. Novel therapeutic strategies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
12
Relapsed/refractory diffuse large B-cell lymphoma: on the threshold of new therapies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
13
Looking back (and ahead) at salvage treatment for non-Hodgkin lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
14
LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
15
Prophylactic central lymph node dissection: continued controversy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
16
Can risk-adapted treatment recommendations replace the 'One size fits all' approach for early-stage thyroid cancer patients?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
17
Low-risk papillary thyroid cancer: treatment options and patient perceptions.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
18
What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
19
Announcements.
- Published in:
- 2009
- Publication type:
- Journal Article
20
Complementary Therapies, Herbs, and Other OTC Agents.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 647
- By:
- Publication type:
- Article
21
'Natural' Hormone Replacement and Breast Cancer Risk: Evidence for Safety and Efficacy.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
22
Vaccine Improves Response Rate and Extends Progression-Free Survival in Metastatic Melanoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 642
- Publication type:
- Article
23
LHRH Antagonists vs LHRH Agonists: Which Is More Beneficial in Prostate Cancer Therapy?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 631
- By:
- Publication type:
- Article
24
PARP Inhibitors Show Promise for Hard-to-Treat Breast Cancers.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 638
- Publication type:
- Article
25
Maintenance Therapy With Pemetrexed Improves Overall Survival in Advanced NSCLC.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 638
- Publication type:
- Article
26
Relapsed/Refractory Diffuse Large B-cell Lymphoma: On the Threshold of New Therapies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 615
- By:
- Publication type:
- Article
27
Is There a Role for LHRH Antagonists in Prostate Cancer?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 632
- By:
- Publication type:
- Article
28
Therapeutic Cancer Vaccine Significantly Prolongs Disease-Free Survival for Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 642
- Publication type:
- Article
29
Can Risk-Adapted Treatment Recommendations Replace the 'One Size Fits All' Approach for Early-Stage Thyroid Cancer Patients?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 592
- By:
- Publication type:
- Article
30
Looking Back (and Ahead) at Salvage Treatment for Non-Hodgkin Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 619
- By:
- Publication type:
- Article
31
Important Considerations in LHRH Antagonist Therapy for Prostate Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 636
- By:
- Publication type:
- Article
32
Announcements.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 571
- Publication type:
- Article
33
Prophylactic Central Lymph Node Dissection: Continued Controversy.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 603
- By:
- Publication type:
- Article
34
The Role of LHRH Antagonists in the Treatment of Prostate Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 626
- By:
- Publication type:
- Article
35
Low-Risk Papillary Thyroid Cancer: Treatment Options and Patient Perceptions.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 589
- By:
- Publication type:
- Article
36
What Is the Optimal Initial Treatment of Low-Risk Papillary Thyroid Cancer (and Why Is It Controversial)?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 579
- By:
- Publication type:
- Article
37
Therapeutic Options in Relapsed or Refractory Diffuse Large B-cell Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 610
- By:
- Publication type:
- Article